Get the Stockscreener App
1.61
3.59%
-0.06
After Hours:
1.60
-0.01
-0.62%
Myomo Inc stock is traded at $1.61, with a volume of 219.55K.
It is down -3.59% in the last 24 hours and up +8.78% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$1.67
Open:
$1.66
24h Volume:
219.55K
Relative Volume:
0.36
Market Cap:
$63.77M
Revenue:
$41.21M
Net Income/Loss:
$-15.12M
P/E Ratio:
-4.4735
EPS:
-0.3599
Net Cash Flow:
$-17.19M
1W Performance:
+8.78%
1M Performance:
+8.78%
6M Performance:
+131.22%
1Y Performance:
+76.92%
1-Day Range:
$1.60
$1.70
1-Week Range:
$1.47
$1.71
52-Week Range:
$0.605
$1.885
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.61 | 63.77M | 41.21M | -15.12M | -17.19M | -0.3599 |
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
Myomo raises FY26 sales guidance to $45-47 million range - scanx.trade
Myomo Q2FY26 Results: Revenue up 21%, guidance raised to $45-47 million - scanx.trade
Myomo Q2 2026 Earnings Call Transcript - Benzinga
Myomo Inc. (MYO) Q2 2026 Earnings: Wider-Than-Expected Loss Met With Modest Stock GainQuarterly Earnings Report - dars.gov.et
ETFs Investing in Myomo, Inc. Stocks - TradingView
Myomo Inc (MYO) Chief Medical Officer Harry Kovelman Sells 15,48 - GuruFocus
Myomo (NYSE: MYO) insider to sell 15,844 shares after two recent sales - Stock Titan
Director of Myomo (NYSE: MYO) moves to sell shares from recent stock awards - Stock Titan
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeFactor Valuation - vinanet.vn
MYO Q2 2026 Earnings: EPS Miss of 18.81% Sends Shares Down 4.9%Earnings Decline Risk - vinanet.vn
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - BioSpace
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Ascendiant Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $10.5 - Moomoo
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com Nigeria
Myomo CMO Harry Kovelman sells $30,329 in stock - Investing.com
Myomo (MYO) Latest: Moves 0.57% Lower to $1.73 on the Day; Technical View - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionGross Profit Margin - vinanet.vn
Myomo chief medical officer sells $29,895 in shares - Investing.com India
Insider Selling: Myomo (NYSEAMERICAN:MYO) Insider Sells 17,250 Shares of Stock - MarketBeat
Myomo chief medical officer sells $29,895 in shares By Investing.com - Investing.com South Africa
Myomo (NYSE: MYO) officer eyes 17,500-share stock sale - Stock Titan
Rosalind Advisors, Inc. Expands Myomo Inc (MYO) Stake -- Shares Trade 48% Below GF Value - GuruFocus
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock - qz.com
Myomo Inc. (MYO) Q2 2026 Earnings: EPS Misses Estimates as Loss Deepens, Shares Edge Up - Vinanet
Myomo (MYO): Rosalind Master Fund reports 9.18% stake and warrant blocker - Stock Titan
Q1 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Q3 Earnings Estimate for Myomo Issued By HC Wainwright - MarketBeat
MYO Q2 2026 Earnings: EPS Miss of 18.8% Weighs on Shares as Loss DeepensProfit Recovery Report - dars.gov.et
Myomo Q2 Earnings Call Highlights - sharewise.com
A Quick Look at Today's Ratings for Myomo(MYO.US), With a Forecast Between $1.7 to $5 - Moomoo
Myomo revenue up 21% to USD 11.7M in Q2 2026 - Medical Buyer
Myomo earnings beat by $0.01, revenue topped estimates - Investing.com Nigeria
Craig-Hallum Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $1.7 - Moomoo
Myomo Inc. (MYO) Surges 19% as Medical Robotics Stock Tests Key ResistanceOvervalued Signals - dars.gov.et
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive Strong Quarter - GuruFocus
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive ... - Yahoo Finance
Myomo Reports Second Quarter 2026 Financial and Operating Results - BioSpace
Earnings call transcript: Myomo tops Q2 2026 estimates and lifts revenue view - Investing.com
Is Myomo Inc (MYO) a Hidden Gem? Q2 Earnings Show Revenue of $11 - GuruFocus
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Aug 05 (Reuters)Myomo Inc Q2 Operating Exp - Moomoo
MYOMO INC Q2 NET INCOME USD -1.2 MILLION - Moomoo
Q2 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Press Release: Myomo Reports Second Quarter 2026 Financial and Operating Results - moomoo.com
Myomo(MYO) Stock Options Chain | Quotes & News - Moomoo
Myomo Q3 Results: Sales guidance beats analyst estimates - scanx.trade
MYO Q1 2026 Earnings: Loss Narrows to $0.05 Per Share, Beating Estimates by 56.6%Tangible Book Value - vinanet.vn
Myomo Adds Seventh Director to its Board - mpo-mag.com
Earnings Preview: Myomo to Report Financial Results Post-market on August 05 - Moomoo
Myomo Inc. (MYO) Pushes Toward Resistance After 7.5% Gain — Key Levels to WatchJelly Roll Trade - careplusvn.com
Myomo Inc. Q1 2026 Earnings: Wider-Than-Expected Loss but Significant EPS Surprise Marks ProgressQuarterly Profit Report - dars.gov.et
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):